Spence, Holly
Waldron, Fergal M.
Saleeb, Rebecca S.
Brown, Anna-Leigh
Rifai, Olivia M.
Gilodi, Martina
Read, Fiona
Roberts, Kristine
Milne, Gillian
Wilkinson, Debbie
O’Shaughnessy, Judi
Pastore, Annalisa
Fratta, Pietro
Shneider, Neil
Tartaglia, Gian Gaetano
Zacco, Elsa
Horrocks, Mathew H.
Gregory, Jenna M. http://orcid.org/0000-0003-3337-4079
Funding for this research was provided by:
Target ALS (BB-2022-C4-L2)
NIH (R01NS127186)
HORIZON EUROPE European Research Council (RIBOMYLOME_309545, ASTRA_855923)
Article History
Received: 28 November 2023
Revised: 11 February 2024
Accepted: 12 February 2024
First Online: 5 March 2024
Declarations
:
: GGT, EZ, AP, MH are listed as inventors on a patent relating to the use of TDP-43 binding RNA aptamers: “WO2023217742—TDP-43-BINDING SINGLE-STRANDED APTAMERS AND USES THEREOF” (PCT/EP2023/062203). The authors declare no other conflicts of interest.